Cubist Systematic Strategies’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $255K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $113K | Sell |
|
|||||
|
2024
Q1 | $380K | Sell |
|
|||||
|
2023
Q4 | $544K | Buy |
|
|||||
|
2023
Q3 | $417K | Buy |
|
|||||
|
2023
Q2 | $153K | Sell |
|
|||||
|
2023
Q1 | $253K | Buy |
|
|||||
|
2022
Q4 | $198K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $189K | Sell |
|
|||||
|
2022
Q1 | $899K | Sell |
|
|||||
|
2021
Q4 | $3.81M | Buy |
|
|||||
|
2021
Q3 | $281K | Sell |
|
|||||
|
2021
Q2 | $976K | Buy |
|
|||||
|
2021
Q1 | $303K | Buy |
|